1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Infectious
Disease Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Service (Assays, Kits,
Reagents, Instruments, Services & Software)
5.2.2. By Technology (Molecular Diagnostics,
Immunoassay, Microbiology, Others)
5.2.3. By Disease (Hepatitis, Human Papillomavirus
(HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired
Infections (HAIs), Others)
5.2.4. By End User (Hospital and Clinical
Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes,
Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
6.
North America Infectious
Disease Testing Market Outlook
6.1.
Market Size &
Forecast
6.1.1. By Value
6.2.
Market Share &
Forecast
6.2.1.
By Product & Service
6.2.2. By Technology
6.2.3.
By Disease
6.2.4.
By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Infectious Disease Testing
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product &
Service
6.3.1.2.2.
By Technology
6.3.1.2.3.
By Disease
6.3.1.2.4.
By End User
6.3.2. Canada Infectious Disease Testing
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product &
Service
6.3.2.2.2.
By Technology
6.3.2.2.3.
By Disease
6.3.2.2.4.
By End User
6.3.3. Mexico Infectious Disease Testing
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product &
Service
6.3.3.2.2.
By Technology
6.3.3.2.3.
By Disease
6.3.3.2.4.
By End User
7.
Europe Infectious
Disease Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Service
7.2.2. By Technology
7.2.3. By Disease
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Infectious Disease Testing
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product &
Service
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Disease
7.3.1.2.4.
By End User
7.3.2. United Kingdom Infectious Disease Testing
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product &
Service
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Disease
7.3.2.2.4.
By End User
7.3.3. Italy Infectious Disease Testing
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Product &
Service
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Disease
7.3.3.2.4.
By End User
7.3.4. France Infectious Disease Testing
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product & Service
7.3.4.2.2.
By Technology
7.3.4.2.3.
By Disease
7.3.4.2.4.
By End User
7.3.5. Spain Infectious Disease Testing
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product &
Service
7.3.5.2.2.
By Technology
7.3.5.2.3.
By Disease
7.3.5.2.4.
By End User
8.
Asia-Pacific Infectious
Disease Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Service
8.2.2. By Technology
8.2.3. By Disease
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Infectious Disease Testing
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product &
Service
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Disease
8.3.1.2.4.
By End User
8.3.2. India Infectious Disease Testing
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product &
Service
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Disease
8.3.2.2.4.
By End User
8.3.3. Japan Infectious Disease Testing
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product &
Service
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Disease
8.3.3.2.4.
By End User
8.3.4. South Korea Infectious Disease Testing
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product &
Service
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Disease
8.3.4.2.4.
By End User
8.3.5. Australia Infectious Disease Testing
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product &
Service
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Disease
8.3.5.2.4.
By End User
9.
South America Infectious
Disease Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Service
9.2.2. By Technology
9.2.3. By Disease
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Infectious Disease Testing
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product &
Service
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Disease
9.3.1.2.4.
By End User
9.3.2. Argentina Infectious Disease Testing
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product &
Service
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Disease
9.3.2.2.4.
By End User
9.3.3. Colombia Infectious Disease Testing
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product &
Service
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Disease
9.3.3.2.4.
By End User
10.
Middle East and
Africa Infectious Disease Testing Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Product & Service
10.2.2. By Technology
10.2.3. By Disease
10.2.4. By End User
10.2.5. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Infectious Disease Testing
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Product &
Service
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Disease
10.3.1.2.4.
By End User
10.3.2. Saudi Arabia Infectious Disease Testing
Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product &
Service
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Disease
10.3.2.2.4.
By End User
10.3.3. UAE Infectious Disease Testing
Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Product &
Service
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Disease
10.3.3.2.4.
By End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Infectious Disease Testing Market:
SWOT Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Product
15. Competitive Landscape
15.1.
Business Overview
15.2.
Service Offerings
15.3.
Recent Developments
15.4.
Key Personnel
15.5.
SWOT Analysis
15.5.1. Biomérieux SA
15.5.2. Abbott Laboratories Inc.
15.5.3. Becton, Dickinson and Company
15.5.4. Bio-Rad Laboratories Inc.
15.5.5. Danaher Corporation
15.5.6. F. Hoffmann-La Roche AG
15.5.7. Siemens Healthineers AG
15.5.8. Thermo Fisher Scientific Inc.
15.5.9. Quidel Corporation
15.5.10.
Trinity Biotech PLC
16.
Strategic Recommendations
17. About Us & Disclaimer